propranolol has been researched along with doxazosin in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (17.39) | 18.7374 |
1990's | 5 (21.74) | 18.2507 |
2000's | 9 (39.13) | 29.6817 |
2010's | 3 (13.04) | 24.3611 |
2020's | 2 (8.70) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Colagrande, F; Jackman, GP; Louis, WJ | 1 |
Elsegood, CL; Mackintosh, VS; Redgrave, TG | 1 |
Jansen, H | 1 |
Baggen, RG; Jansen, H | 1 |
Ontko, JA; Woodside, WF | 1 |
Baggen, MG; Birkenhäger, JC; Jansen, H; Lammers, R | 1 |
Jie, K; Timmermans, PB; van Brummelen, P; van Zwieten, PA; Vermey, P | 1 |
Birkeland, S; Brunvand, H; Grong, K; Hexeberg, E; Rynning, SE | 1 |
Berge, RK; Brunvand, H; Grong, K; Kvitting, PM; Rynning, SE | 1 |
Borea, PA; Caiazza, A; Gessi, S; Manfredini, R; Portaluppi, F; Varani, K | 1 |
Aizawa, Y; Chinushi, M; Furushima, H; Washizuka, T | 1 |
Borea, PA; Cattabriga, E; Iannotta, V; Manfredini, R; Pancaldi, C; Portaluppi, F; Uluoglu, C; Varani, K | 1 |
Busca, G; Clari, F; Facoetti, A; Fallarini, S; Ferrari, AU; Ferrero, I; Fogari, R; Nano, R; Palladini, G; Perlini, S; Tozzi, R | 1 |
Busca, G; Cesana, F; Clari, F; Ferrari, AU; Ferrero, I; Gatti, C; Janetti, MB; Mancia, G; Palladini, G; Perlini, S; Tozzi, R; Vezzoli, M | 1 |
Cadirci, E; Gocer, F; Hacimuftuoglu, A; Halici, Z; Keles, S; Suleyman, H | 1 |
Abzalov, NI; Abzalov, RA; Gulyakov, AA; Nikitin, AS; Vafina, EZ | 1 |
Angele, P; El Bagdadi, K; Grässel, S; Hedderich, J; Jenei-Lanzl, Z; Meurer, A; Straub, RH; Zaucke, F | 1 |
1 review(s) available for propranolol and doxazosin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for propranolol and doxazosin
Article | Year |
---|---|
Vascular alpha-adrenoceptors in man: interactions with adrenaline and noradrenaline.
Topics: Adult; Doxazosin; Epinephrine; Forearm; Humans; Male; Muscle, Smooth, Vascular; Norepinephrine; Prazosin; Propranolol; Receptors, Adrenergic, alpha; Vasoconstriction; Yohimbine | 1985 |
Role of alpha1-blockade in congenital long QT syndrome: investigation by exercise stress test.
Topics: Adolescent; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Doxazosin; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Propranolol | 2001 |
Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension.
Topics: Adenosine-5'-(N-ethylcarboxamide); Adult; Antihypertensive Agents; Binding, Competitive; Blood Pressure; Body Mass Index; Cyclic AMP; Diastole; Doxazosin; Female; Humans; Hypertension; Lymphocytes; Male; Middle Aged; Neutrophils; Propranolol; Radioligand Assay; Receptor, Adenosine A2A; Receptors, Purinergic P1; Reference Values; Systole; Treatment Outcome; Triazines; Triazoles | 2002 |
19 other study(ies) available for propranolol and doxazosin
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Validation of a solid-phase extraction high-performance liquid chromatographic assay for doxazosin.
Topics: Adrenergic alpha-Antagonists; Chromatography, High Pressure Liquid; Doxazosin; Humans; Hydrogen-Ion Concentration; Methanol; Prazosin; Propranolol | 1991 |
Effects of adrenoreceptor antagonists and agonists on clearance of emulsion models of triacylglycerol-rich lipoproteins from plasma in rats.
Topics: Adrenergic Agonists; Adrenergic alpha-Antagonists; Adrenergic Antagonists; Angiotensin II; Animals; Cholesterol Esters; Doxazosin; Emulsions; Fenoterol; Isoproterenol; Lipoprotein Lipase; Lipoproteins; Male; Norepinephrine; Phenylephrine; Prazosin; Propranolol; Rats; Rats, Inbred Strains; Rats, Inbred WKY; Receptors, Adrenergic; Triglycerides | 1991 |
The mode of action of alpha 1-adrenoceptor blockers on blood lipids.
Topics: Animals; Atenolol; Cholesterol, Dietary; Cholesterol, HDL; Cricetinae; Doxazosin; Humans; Lipoprotein Lipase; Mesocricetus; Prazosin; Propranolol; Time Factors; Triglycerides | 1990 |
Effects of doxazosin and propranolol administration on lipoprotein lipases in cholesterol-fed rats.
Topics: Adipose Tissue; Adrenergic alpha-Antagonists; Animals; Cholesterol, Dietary; Doxazosin; Insulin; Lipids; Lipoprotein Lipase; Liver; Male; Myocardium; Prazosin; Propranolol; Rats; Rats, Inbred Strains; Thyroid Hormones | 1987 |
Regulation of triglyceride mobilization in isolated hepatocytes by dibutyryl cyclic AMP and epinephrine.
Topics: Adrenergic alpha-Antagonists; Animals; Bucladesine; Chloroquine; Doxazosin; Epinephrine; Epoxy Compounds; Fatty Acids; Lipid Mobilization; Liver; Male; Prazosin; Propranolol; Rats; Triglycerides | 1989 |
Effects of doxazosin on lipids, lipoprotein lipases, and cholesterol synthesis in the golden hamster.
Topics: Adrenergic alpha-Antagonists; Animals; Atenolol; Cholesterol; Cholesterol, Dietary; Cricetinae; Doxazosin; Insulin; Lipase; Lipoprotein Lipase; Liver; Male; Mesocricetus; Norepinephrine; Prazosin; Propranolol; Thyroid Hormones; Triglycerides | 1989 |
Endogenous adenosine attenuates myocardial stunning by antiadrenergic effects exerted during ischemia and not during reperfusion.
Topics: Adenosine; Animals; Cats; Coronary Circulation; Doxazosin; Heart; Hemodynamics; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Propranolol; Purinergic P1 Receptor Antagonists; Sympathetic Nervous System; Theophylline | 1995 |
Carvedilol protects against lethal reperfusion injury through antiadrenergic mechanisms.
Topics: Adrenergic Antagonists; Animals; Carbazoles; Carvedilol; Cats; Doxazosin; Free Radical Scavengers; Glutathione; Heart; Hemodynamics; Male; Myocardial Reperfusion Injury; Myocardium; Propanolamines; Propranolol; Thiobarbituric Acid Reactive Substances | 1996 |
Platelet alpha2-adrenoceptor alterations in patients with essential hypertension are normalized after treatment with doxazosin but not propranolol.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Blood Platelets; Brimonidine Tartrate; Case-Control Studies; Cell Membrane; Doxazosin; Female; Humans; Hypertension; In Vitro Techniques; Kinetics; Male; Middle Aged; Propranolol; Quinoxalines; Receptors, Adrenergic, alpha-2 | 2000 |
Sympathectomy or doxazosin, but not propranolol, blunt myocardial interstitial fibrosis in pressure-overload hypertrophy.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiomegaly; Collagen; Doxazosin; Fibrosis; Hypertension; Lung; Male; Matrix Metalloproteinase 2; Myocardium; Propranolol; Rats; Rats, Sprague-Dawley; Sympathectomy, Chemical; Tissue Inhibitor of Metalloproteinase-2 | 2005 |
Survival benefits of different antiadrenergic interventions in pressure overload left ventricular hypertrophy/failure.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Aorta, Abdominal; Blood Pressure; Doxazosin; Heart Failure; Heart Rate; Hypertension; Hypertrophy, Left Ventricular; Male; Oxidopamine; Propranolol; Rats; Rats, Sprague-Dawley; Sympathectomy, Chemical | 2006 |
Indirect role of alpha2-adrenoreceptors in anti-ulcer effect mechanism of nimesulide in rats.
Topics: Adrenalectomy; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; alpha-Methyltyrosine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Corticosterone; Desoxycorticosterone; Dose-Response Relationship, Drug; Doxazosin; Epinephrine; Indomethacin; Male; Metyrapone; Prednisolone; Propranolol; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Stomach Ulcer; Sulfonamides; Yohimbine | 2007 |
Regulation of pumping function of the heart in developing body under changing regimens of motor activity.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Cardiac Output; Doxazosin; Heart; Hypokinesia; Propranolol; Rats; Stroke Volume | 2014 |
Norepinephrine Inhibits the Proliferation of
Topics: Adult; Aged; Bone Marrow Cells; Cell Proliferation; Cell Survival; Cells, Cultured; Chondrocytes; Cyclic AMP-Dependent Protein Kinases; Doxazosin; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression Profiling; Humans; Male; MAP Kinase Signaling System; Mesenchymal Stem Cells; Middle Aged; Neurotransmitter Agents; Norepinephrine; Phosphorylation; Propranolol; Receptors, Adrenergic, beta-2; Signal Transduction; Yohimbine; Young Adult | 2020 |